[Chronic juvenile arthritis. Control of long-term therapy].
Children suffering from juvenile chronic arthritis need a longterm therapy and guidance for many years. Drug therapy is only part of the whole treatment regimen and has to be permanently adapted to the actual state of the disease. Drug induced side effects must be strictly differentiated from exacerbations of the rheumatic disease. Short time clinical controls, some few laboratory tests and many detailed talks with the patient and his parents are basic requirements for successful treatment and lead in more than 80% of the juveniles to a normal school education and adequate vocational training.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000505:Alopecia / Q000139:chemically induced; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002738:Chloroquine / Q000009:adverse effects / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D007978:Levamisole / Q000627:therapeutic use; D008134:Long-Term Care; D010396:Penicillamine / Q000627:therapeutic use; D010859:Pigmentation Disorders / Q000139:chemically induced; D013272:Stomach Diseases / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007978:Levamisole; D006046:Gold; D002738:Chloroquine; D010396:Penicillamine
Juvenile chronische Arthritis. Kontrolle der Langzeittherapie.